AI Analysis AI Analysis of CLDX
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Red day on Friday for Celldex Therapeutics stock after losing 1.54%
(Updated on Jun 20, 2025)

Buy candidate since Jun 18, 2025 Loss -1.54%

The Celldex Therapeutics stock price fell by -1.54% on the last day (Friday, 20th Jun 2025) from $20.82 to $20.50. During the last trading day the stock fluctuated 4.62% from a day low at $20.12 to a day high of $21.05. The price has fallen in 6 of the last 10 days but is still up by 4.97% over the past 2 weeks. Volume has increased on the last day by 314 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $21.25 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.88% during the next 3 months and, with a 90% probability hold a price between $19.81 and $26.23 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

CLDX Signals & Forecast

The Celldex Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $20.54. On a fall, the stock will find some support from the long-term average at approximately $20.06. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 28, 2025, and so far it has fallen -4.03%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $20.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.93 between high and low, or 4.62%. For the last week, the stock has had daily average volatility of 8.18%.

Our recommended stop-loss: $19.62 (-4.27%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 37 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Monday 23rd

For the upcoming trading day on Monday, 23rd we expect Celldex Therapeutics to open at $20.56, and during the day (based on 14 day Average True Range), to move between $19.22 and $21.78, which gives a possible trading interval of +/-$1.28 (+/-6.25%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 12.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $20.35 (0.73%) than the resistance at $20.71 (1.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Celldex Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term.

Current score: 1.088 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2025 - $20.56 ( 0.276%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

CLDX Performance

Trading levels for CLDX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 21.49 4.81%
R2 21.13 3.08%
R1 20.91 2.01%
Price 20.50
S1 20.20 -1.46%
S2 19.98 -2.53%
S3 19.63 -4.26%

Accumulated Volume Support & Resistance Levels

Level Price
R3 21.36 4.20%
R2 21.26 3.71%
R1 20.71 1.02%
Price 20.50
S1 20.35 -0.732%
S2 19.87 -3.07%
S3 19.84 -3.22%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the Jun 20, 2025, the price of an Celldex Therapeutics (CLDX) share was $20.50.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $47.00 and the 52-week low is $14.40.

What is the market capitalization of Celldex Therapeutics Stock?
As of the Jun 20, 2025, the market capitalization of Celldex Therapeutics is 1.382B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is Aug 14, 2025.
Click to get the best stock tips daily for free!
ABOUT CELLDEX THERAPEUTICS
Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
2.40% Jun 02
TAC
$8.90
23.37% May 12
IMMR
$7.28
4.81% May 09
UAA
$5.84
20.38% May 09
MEDP
$300.81
2.84% May 08

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE